<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POLE — DNA Polymerase Epsilon</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>POLE</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Epsilon</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12q24.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5426" target="_blank">5426</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177042" target="_blank">ENSG00000177042</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/174762" target="_blank">174762</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q07864" target="_blank">Q07864</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>DNA polymerase, B family</td>
</tr>
<tr>
<td class="label">Molecular Function</td>
<td>DNA-directed DNA polymerase activity, 3'-5' exonuclease activity</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Colorectal Cancer, FILS Syndrome, DNA Polymerase Proofreading Deficiency</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">See Disease Associations section for variants</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">148 edges</a></td>
</tr>
</table>
POLE (DNA Polymerase Epsilon) is a gene located on chromosome 12q24.3 that encodes the catalytic subunit of DNA polymerase epsilon, a key enzyme involved in DNA replication and repair. POLE is essential for accurate genome maintenance and plays a critical role in protecting neurons from DNA damage accumulation that leads to neurodegenerative diseases. The gene is catalogued as NCBI Gene ID [5426](https://www.ncbi.nlm.nih.gov/gene/5426) and OMIM [174762](https://omim.org/entry/174762).
DNA polymerase epsilon (Pol ε) is a high-fidelity B-family DNA polymerase that functions primarily in lagging strand synthesis during DNA replication and participates in long-patch base excision repair (LP-BER). The proofreading 3'-5' exonuclease activity of POLE provides essential error correction, with mutant forms exhibiting dramatically increased mutation rates in replicating cells.
POLE encodes the catalytic (large) subunit of the Pol ε holoenzyme, which possesses three distinct enzymatic activities:
The Pol ε complex consists of four subunits:
During S-phase of the cell cycle, Pol ε functions as the primary polymerase for lagging strand synthesis. It works in conjunction with [DNA polymerase alpha](/proteins/dna-polymerase-alpha) (which initiates synthesis) and [DNA polymerase delta](/proteins/dna-polymerase-delta) to complete Okazaki fragment synthesis. The proofreading activity ensures faithful duplication of the genome.
Beyond replication, POLE participates in several DNA repair pathways:
Long-Patch Base Excision Repair (LP-BER): POLE's strand displacement activity allows it to synthesize a patch of 2-10 nucleotides, replacing damaged base removal products. This is particularly important in neurons exposed to oxidative stress.
Mismatch Repair (MMR): Pol ε contributes to the final excision step of MMR, synthesizing DNA to replace mispaired bases after nick-directed excision.
Nucleotide Excision Repair (NER): While primarily handled by polymerases δ and ε, Pol ε can participate in DNA synthesis during NER of bulky adducts.
POLE is expressed in multiple brain regions critical to neurodegenerative disease pathogenesis:
Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=POLE).
Neurons accumulate DNA damage throughout the lifespan from multiple sources:
The [DNA damage response](/mechanisms/dna-damage-response) (DDR) activates checkpoint kinases ATM, ATR, and DNA-PKcs, leading to p53 activation and either cell cycle arrest or apoptosis. In neurons, chronic DDR activation can trigger neurodegenerative processes.
Multiple mechanisms link POLE dysfunction to [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis:
Accelerated mutation accumulation: Impaired proofreading due to POLE mutations leads to increased somatic mutations in neurons. Studies have demonstrated significantly elevated mutation loads in AD brains compared to age-matched controls.
Genomic instability in glia: Reduced POLE function in supporting glial cells may compromise their supportive functions for neurons, contributing to synaptic dysfunction.
Epigenetic alterations: DNA polymerase dysfunction can affect epigenetic maintenance, including [DNA methylation](/mechanisms/dna-methylation) patterns that regulate neuroprotective gene expression.
Mitochondrial interactions: The relationship between nuclear DNA repair and mitochondrial DNA maintenance is critical; POLE dysfunction may indirectly affect mitochondrial function in neurons.
Research has identified specific POLE variants in AD patients that show reduced catalytic efficiency, suggesting a potential causative relationship.
The selective vulnerability of dopaminergic neurons in the [substantia nigra](/brain-regions/substantia-nigra) in [Parkinson's Disease](/diseases/parkinsons-disease) may be partially attributable to DNA repair capacity:
Oxidative stress susceptibility: The substantia nigra experiences high oxidative stress due to dopamine metabolism. POLE-mediated base excision repair is essential for removing oxidative DNA lesions.
Mitochondrial DNA damage: While POLE functions in nuclear DNA, coordination between nuclear and mitochondrial DNA repair systems is essential. Defects in nuclear DNA repair may disrupt this balance.
Age-related decline: Age-related decline in POLE expression and activity may accelerate neuronal loss in PD.
POLE mutations and polymorphisms contribute to AD risk through multiple mechanisms:
| Mechanism | Effect on AD Pathogenesis |
|-----------|--------------------------|
| Reduced proofreading | Increased somatic mutations in neurons |
| Impaired BER | Accumulation of oxidative lesions |
| Epigenetic dysregulation | Altered gene expression patterns |
| Genomic instability | Activation of cell death pathways |
In PD, POLE dysfunction may accelerate the loss of dopaminergic neurons:
Germline POLE mutations cause a syndrome known as [DNA polymerase proofreading deficiency](/diseases/fils-syndrome), characterized by:
FILS (Familial Immunodeficiency with Littoral Cell Angiosarcoma) syndrome is caused by POLE mutations and presents with:
| Variant | Location | Effect | Associated Disease |
|---------|----------|--------|-------------------|
| P286R | Exon 13 | Proofreading deficiency | Colorectal cancer |
| V411L | Exon 7 | Catalytic dysfunction | FILS syndrome |
| R446Q | Exon 11 | Reduced activity | AD risk modifier |
Several common POLE polymorphisms have been associated with modified risk for neurodegenerative diseases:
Understanding POLE function has revealed several therapeutic approaches:
PARP inhibitors: [PARP](/proteins/parp1) inhibitors can help by directing repair resources to base excision repair pathways that involve POLE.
Antioxidant therapy: Reducing oxidative stress decreases the DNA damage burden that POLE must repair.
Gene therapy: Potential future approaches could deliver functional POLE to neurons.
Small molecule stabilizers: Compounds that stabilize the Pol ε complex and enhance its activity are under investigation.
POLE interacts with several proteins critical to DNA metabolism:
DNA Damage → ATM/ATR Activation → Cell Cycle Checkpoint
↓
p53 Activation → Apoptosis or Arrest
↓
Base Excision Repair → Pol ε-mediated Synthesis
The following diagram shows the key molecular relationships involving POLE — DNA Polymerase Epsilon discovered through SciDEX knowledge graph analysis: